KD Logo

Ascendiant Capital Markets initates ARCA biopharma Inc (ABIO) rating to a Buy

ARCA biopharma Inc’s filing revealed that its 10% Owner JANUS HENDERSON GROUP PLC acquired Company’s shares for reported $0.61 million on Jul 24 ’24. In the deal valued at $3.20 per share,189,856 shares were bought. As a result of this transaction, JANUS HENDERSON GROUP PLC now holds 2,081,168 shares worth roughly $7.45 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, JANUS HENDERSON GROUP PLC bought 30,227 shares, generating $92,292 in total proceeds. Upon buying the shares at $3.05, the 10% Owner now owns 2,111,395 shares.

Before that, JANUS HENDERSON GROUP PLC bought 166,042 shares. ARCA biopharma Inc shares valued at $589,565 were divested by the 10% Owner at a price of $3.55 per share. As a result of the transaction, JANUS HENDERSON GROUP PLC now holds 1,648,577 shares, worth roughly $5.9 million.

Ascendiant Capital Markets initiated its ARCA biopharma Inc [ABIO] rating to a Buy in a research note published on February 27, 2018; the price target was $2. A number of analysts have revised their coverage, including Dawson James’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating.

Price Performance Review of ABIO

On Monday, ARCA biopharma Inc [NASDAQ:ABIO] saw its stock jump 163.24% to $3.58. Over the last five days, the stock has gained 183.41%. ARCA biopharma Inc shares have risen nearly 356.79% since the year began. Nevertheless, the stocks have risen 280.66% over the past one year. While a 52-week high of $2.07 was reached on 05/17/24, a 52-week low of $0.72 was recorded on 01/19/24. SMA at 50 days reached $3.25, while 200 days put it at $2.48.

Levels Of Support And Resistance For ABIO Stock

The 24-hour chart illustrates a support level at 3.22, which if violated will result in even more drops to 2.85. On the upside, there is a resistance level at 3.81. A further resistance level may holdings at 4.03. The Relative Strength Index (RSI) on the 14-day chart is 90.21, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.20, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 8.40%. Stochastics%K at 65.43% indicates the stock is a holding.

How much short interest is there in ARCA biopharma Inc?

A steep rise in short interest was recorded in ARCA biopharma Inc stocks on 2024-07-31, growing by 0.22 million shares to a total of 4.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 4.18 million shares. There was a rise of 5.01%, which implies that there is a positive sentiment for the stock.

Most Popular